Context Therapeutics Inc (CNTX) — Financial Flexibility Index
Context Therapeutics Inc (CNTX) has a Financial Flexibility Index of -1.71x as of March 2026. Free cash flow of $-11.39 Million (operating CF $-11.43 Million minus capex $37.26K) represents -2% of total liabilities ($6.66 Million). Also explore Context Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Context Therapeutics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Context Therapeutics Inc across 9 annual periods. Check how strategically is Context Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Context Therapeutics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Context Therapeutics Inc. For the full company profile including market capitalisation, see Context Therapeutics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.29x | $-26.35 Million | $-26.39 Million | $8.02 Million | ▼ -4776.0% |
| 2024 | 0.07x | $201.00K | $-14.56 Million | $2.86 Million | ▲ +101.4% |
| 2023 | -5.02x | $-21.05 Million | $-21.05 Million | $4.19 Million | ▼ -23.8% |
| 2022 | -4.06x | $-13.01 Million | $-13.55 Million | $3.21 Million | ▼ -43.9% |
| 2021 | -2.82x | $-8.55 Million | $-8.80 Million | $3.03 Million | ▼ -4636.8% |
| 2020 | -0.06x | $-1.03 Million | $-1.03 Million | $17.39 Million | ▲ +49.2% |
| 2019 | -0.12x | $-2.84 Million | $-2.84 Million | $24.23 Million | ▲ +95.1% |
| 2017 | -2.38x | $-22.32 Million | $-22.35 Million | $9.38 Million | ▲ +15.2% |
| 2016 | -2.80x | $-30.54 Million | $-30.57 Million | $10.89 Million | — |